Table 1
Biochemical and cellular activities of compounds 8, 9, 10 and 11
Compound
R1
P-MET WT IC
50
(nM)
MKN-45
proliferation
IC
50 (nM)
L1195V IC
50
(nM)
M1250T IC
50
(nM)
Y1230H IC
50
(nM)
logD
(pH 7.4)
8
NH
2
10
81
9,000
245
>10,000
>4.6
9
N
H
O
*
3
7
61
13
883
4.7
10
N
O
N
H
O
*
6
12
318
93
1,172
4.3
11
(SAR125844)
N
O
N
H
N
H
O
*
4
7
64
6
204
4.2
P-MET WT: IC50 measured using protein phosphorylation in a biochemical assay. MKN-45 Proliferation: IC50 measured in proliferation assay using MKN-45
cell line. L1195V, M1250T and Y1230H: IC50 measured using corresponding MET mutants in a biochemical assay. logD measured experimentally by high
performance liquid chromatography (HPLC) (Xterra MS C18 column)
Achieving High Levels of Selectivity for Kinase Inhibitors
107
Biochemical and cellular activities of compounds 8, 9, 10 and 11
Compound
R1
P-MET WT IC
50
(nM)
MKN-45
proliferation
IC
50 (nM)
L1195V IC
50
(nM)
M1250T IC
50
(nM)
Y1230H IC
50
(nM)
logD
(pH 7.4)
8
NH
2
10
81
9,000
245
>10,000
>4.6
9
N
H
O
*
3
7
61
13
883
4.7
10
N
O
N
H
O
*
6
12
318
93
1,172
4.3
11
(SAR125844)
N
O
N
H
N
H
O
*
4
7
64
6
204
4.2
P-MET WT: IC50 measured using protein phosphorylation in a biochemical assay. MKN-45 Proliferation: IC50 measured in proliferation assay using MKN-45
cell line. L1195V, M1250T and Y1230H: IC50 measured using corresponding MET mutants in a biochemical assay. logD measured experimentally by high
performance liquid chromatography (HPLC) (Xterra MS C18 column)
Achieving High Levels of Selectivity for Kinase Inhibitors
107
